Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV-Related Cirrhosis: A Landmark Analysis.

3.4 Risk of All‐Cause and Liver‐Related Mortality In the PS‐matched cohort, although aspirin users showed slightly lower risk of all‐cause and liver‐related mortality compared to nonusers, the differences did not reach statistical significance (aHR, 0.86; 95% CI, 0.69–1.07; p = 0.168 for all‐cause mortality; aHR, 0.87; 95% CI, 0.63–1.21; p = 0.416 for liver‐related mortality) (Table S2 ).

also in 111,027 other papers